Literature DB >> 14691251

Thyroid hormone controls the development of connections between the spinal cord and limbs during Xenopus laevis metamorphosis.

Nicholas Marsh-Armstrong1, Liquan Cai, Donald D Brown.   

Abstract

During premetamorphic stages, Xenopus laevis tadpoles expressing either a dominant-negative thyroid hormone (TH) receptor or a type-III iodothyronine deiodinase transgene in the nervous system have reduced TH-induced proliferation in the spinal cord and produce fewer hindlimb-innervating motorneurons. During prometamorphic stages, innervation of the hindlimbs is reduced, and few functional neuromuscular connections are formed. By metamorphic climax, limb movement is impaired, ranging from uncoordinated leg swimming to complete quadriplegia. This phenotype is due to transgene action in the tadpole spinal cord. The requirement of TH for neurogenesis during premetamorphosis is the earliest TH-regulated process reported to date in the sequence of metamorphic changes in anurans. The muscle formed during limb growth was previously shown to be a direct target of TH control. Here, we show that the same is true of the development of spinal cord cells that innervate the limbs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691251      PMCID: PMC314156          DOI: 10.1073/pnas.2136755100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse.

Authors:  W Lin; R W Burgess; B Dominguez; S L Pfaff; J R Sanes; K F Lee
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  Motoneurons of the axial swimming muscles in hatchling Xenopus tadpoles: features, distribution, and central synapses.

Authors:  A Roberts; A Walford; S R Soffe; M Yoshida
Journal:  J Comp Neurol       Date:  1999-08-30       Impact factor: 3.215

3.  Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase.

Authors:  N Marsh-Armstrong; H Huang; B F Remo; T T Liu; D D Brown
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

4.  Diverse developmental programs of Xenopus laevis metamorphosis are inhibited by a dominant negative thyroid hormone receptor.

Authors:  A M Schreiber; B Das; H Huang; N Marsh-Armstrong; D D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

5.  Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.

Authors:  X Yang; S Arber; C William; L Li; Y Tanabe; T M Jessell; C Birchmeier; S J Burden
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

6.  Cell degeneration in the larval ventral horn of Xenopus laevis (Daudin).

Authors:  A HUGHES
Journal:  J Embryol Exp Morphol       Date:  1961-06

7.  Motor neuron-derived retinoid signaling specifies the subtype identity of spinal motor neurons.

Authors:  S Sockanathan; T M Jessell
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

Review 8.  Central circuits controlling locomotion in young frog tadpoles.

Authors:  A Roberts; S R Soffe; E S Wolf; M Yoshida; F Y Zhao
Journal:  Ann N Y Acad Sci       Date:  1998-11-16       Impact factor: 5.691

9.  Germ-line transmission of transgenes in Xenopus laevis.

Authors:  N Marsh-Armstrong; H Huang; D L Berry; D D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

10.  Xenopus Bcl-X(L) selectively protects Rohon-Beard neurons from metamorphic degeneration.

Authors:  L Coen; D du Pasquier; S Le Mevel; S Brown; J Tata; A Mazabraud; B A Demeneix
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

View more
  17 in total

1.  Remodeling of the intestine during metamorphosis of Xenopus laevis.

Authors:  Alex M Schreiber; Liquan Cai; Donald D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

2.  Thyroid hormone controls multiple independent programs required for limb development in Xenopus laevis metamorphosis.

Authors:  Donald D Brown; Liquan Cai; Biswajit Das; Nicholas Marsh-Armstrong; Alexander M Schreiber; Rejeanne Juste
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

3.  Changing a limb muscle growth program into a resorption program.

Authors:  Liquan Cai; Biswajit Das; Donald D Brown
Journal:  Dev Biol       Date:  2006-12-19       Impact factor: 3.582

Review 4.  Amphibian metamorphosis.

Authors:  Donald D Brown; Liquan Cai
Journal:  Dev Biol       Date:  2007-03-23       Impact factor: 3.582

Review 5.  A method for generating transgenic frog embryos.

Authors:  Shoko Ishibashi; Kristen L Kroll; Enrique Amaya
Journal:  Methods Mol Biol       Date:  2008

6.  Remodeling the exocrine pancreas at metamorphosis in Xenopus laevis.

Authors:  Sandeep Mukhi; Jinzhe Mao; Donald D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

7.  Plasticity of auditory medullary-midbrain connectivity across metamorphic development in the bullfrog, Rana catesbeiana.

Authors:  Seth S Horowitz; Judith A Chapman; Andrea Megela Simmons
Journal:  Brain Behav Evol       Date:  2006-08-14       Impact factor: 1.808

8.  Endogenous dopamine suppresses initiation of swimming in prefeeding zebrafish larvae.

Authors:  Vatsala Thirumalai; Hollis T Cline
Journal:  J Neurophysiol       Date:  2008-06-18       Impact factor: 2.714

9.  Using whole mount in situ hybridization to examine thyroid hormone deiodinase expression in embryonic and larval zebrafish: a tool for examining OH-BDE toxicity to early life stages.

Authors:  Wu Dong; Laura J Macaulay; Kevin W H Kwok; David E Hinton; Heather M Stapleton
Journal:  Aquat Toxicol       Date:  2013-03-04       Impact factor: 4.964

Review 10.  Harnessing vocal patterns for social communication.

Authors:  Lora B Sweeney; Darcy B Kelley
Journal:  Curr Opin Neurobiol       Date:  2014-07-02       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.